Scientific paper - Original scientific paper
Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia
CNS Neuroscience & Therapeutics, 24 (2018), 8; 734-740. https://doi.org/10.1111/cns.12814

Kiđemet-Piskač, Spomenka; Babić Leko, Mirjana; Blažeković, Antonela; Langer Horvat, Lea; Klepac, Nataša; Sonicki, Zdenko; Kolenc, Danijela; Hof, Patrick R.; Boban, Marina; Mimica, Ninoslav; Borovečki, Fran; Šimić, Goran

Cite this document

Kiđemet Piskač, S., Babić Leko, M., Blažeković, A., Langer Horvat, L., Klepac, N., Sonicki, Z. ... Šimić, G. (2018). Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia. CNS Neuroscience & Therapeutics, 24. (8), 734-740. doi: 10.1111/cns.12814

Kiđemet Piskač, Spomenka, et al. "Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia." CNS Neuroscience & Therapeutics, vol. 24, no. 8, 2018, pp. 734-740. https://doi.org/10.1111/cns.12814

Kiđemet Piskač, Spomenka, Mirjana Babić Leko, Antonela Blažeković, Lea Langer Horvat, Nataša Klepac, Zdenko Sonicki, Danijela Kolenc, et al. "Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia." CNS Neuroscience & Therapeutics 24, no. 8 (2018): 734-740. https://doi.org/10.1111/cns.12814

Kiđemet Piskač, S., et al. (2018) 'Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia', CNS Neuroscience & Therapeutics, 24(8), pp. 734-740. doi: 10.1111/cns.12814

Kiđemet Piskač S, Babić Leko M, Blažeković A, Langer Horvat L, Klepac N, Sonicki Z, and sur.. Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia. CNS Neuroscience & Therapeutics [Internet]. 2018 August [cited 2024 June 23];24(8):734-740. doi: 10.1111/cns.12814

S. Kiđemet Piskač, et al., "Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia", CNS Neuroscience & Therapeutics, vol. 24, no. 8, pp. 734-740, August 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:920903. [Accessed: 23 June 2024]